Schering-Plough Appoints Michael Perelman, M.D., Vice President, Global Project Management, Schering-Plough Re

home   >   MSN news

... channel head for Cardiovascular and MetabolicProducts, including ZETIA and VYTORIN in February 2004 and will continue ...

- link to Schering-Plough Appoints Michael Perelman, M.D., Vice President, Global Project Management, Schering-Plough Re -
Last update: 05/26/2005

Recommended Reading

    Natalizumab maintains remission in Crohn's; drug blocks immune cell movement.(News) : An article from: Family Practice News
    Remicade[R] associated with risks of hepatotoxicity and pneumonia.(PIPELINE PREVIEWS) : An article from: Journal of Drugs in Dermatology
    Remicade - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References
    Barrio, Macedo de la Concha y Peyrot: Impugnables.(actos polticos comprometedores de candidatos ministeriales; Mxico)(TT: Barrio, Macedo de la Concha ... o)(Artculo Breve) : An article from: Siempre!
    NEW DRUGS: A DOSE OF REALITY. : An article from: Columbia Journalism Review
    Tysabri, Nexium.(New & Approved) : An article from: Family Practice News
    From a twinkle in the eye to a blockbuster drug: the story of Celebrex[R] holds lessons for R&D leaders everywhere. (The IRI Medalist's Address).(Brie ... article from: Research-Technology Management
    Celebrex - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References